Riggs Asset Management’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1
Closed -$33 – 373
2025
Q2
$33 Hold
1
– – ﹤0.01% 914
2025
Q1
$27 Hold
1
– – ﹤0.01% 634
2024
Q4
$30 Hold
1
– – ﹤0.01% 640
2024
Q3
$27 Hold
1
– – ﹤0.01% 632
2024
Q2
$28 Buy
+1
New +$27 ﹤0.01% 650
2018
Q4
– Sell
-62,073
Closed -$2.39M – 241
2018
Q3
$2.39M Sell
62,073
-524
-0.8% -$19.3K 1.17% 26
2018
Q2
$2.2M Buy
62,597
+40
+0.1% +$1.4K 0.97% 31
2018
Q1
$2.08M Buy
62,557
+1,080
+2% +$36.8K 0.86% 35
2017
Q4
$2.04M Buy
+61,477
New +$2.04M 0.82% 37

Other funds holding FFTY

Riggs Asset Management's FFTY Position: Q3 2025 in Review

Riggs Asset Management sold out of CapForce IBD 50 ETF (FFTY) in Q3 2025, closing a stake of 1 share — an estimated $33 sold.

Riggs Asset Management first reported a position in FFTY in Q4 2017 and held it in 9 quarters. The position peaked at $2.39M in Q3 2018. 40 funds tracked by Wall St. Rank hold FFTY as of Q3 2025.

  • Riggs Asset Management reported no remaining CapForce IBD 50 ETF position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 1 CapForce IBD 50 ETF share in Q3 2025, an estimated $33.
  • Riggs Asset Management first reported a position in CapForce IBD 50 ETF in Q4 2017 and held it in 9 quarters.
  • Riggs Asset Management's CapForce IBD 50 ETF position peaked at $2.39M in Q3 2018.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.